Q4 2020 13F Holders as of 12/31/2020
-
Type / Class
-
Equity / ISHARES BIOTECH
-
Number of holders
-
832
-
Total shares
-
58.4M
-
Shares change
-
+6.57M
-
Total reported value, excl. options
-
$8.85B
-
Value change
-
+$1.02B
-
Put/Call ratio
-
1.91
-
Number of buys
-
324
-
Number of sells
-
-313
-
Price
-
$151.49
Significant Holders of ISHARES TR - ISHARES BIOTECH (IBB) as of Q4 2020
875 filings reported holding IBB - ISHARES TR - ISHARES BIOTECH as of Q4 2020.
ISHARES TR - ISHARES BIOTECH (IBB) has 832 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 58.4M shares
.
Largest 10 shareholders include BANK OF AMERICA CORP /DE/ (13.7M shares), MORGAN STANLEY (8.17M shares), GOLDMAN SACHS GROUP INC (6.17M shares), HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND (5.44M shares), UBS Group AG (2.24M shares), CITIGROUP INC (1.77M shares), BARCLAYS PLC (1.36M shares), ROYAL BANK OF CANADA (1.28M shares), CHURCHILL MANAGEMENT Corp (1.21M shares), and BANK OF NOVA SCOTIA (1M shares).
This table shows the top 832 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.